Cardiac Excitability and Antiarrhythmic Drugs: A Different Perspective

A matrix of active and passive cellular properties determines net cardiac excitability. The hypothesis of altered excitability suggests that for cardiac arrhythmias to arise, the normal matrix must be perturbed by arrhythmogenic influences to produce a proarrhythmic metrical configuration to permit rhythm disturbances caused by abnormalities of propagation, abnormal automaticity, or altered excitability. Antiarrhythmic drugs may act with one or more components of the normal or proarrhythmic matrix to normalize or to create new antiarrhythmic or, perhaps, proarrhythmic matrices. Traditionally, antiarrhythmic drug classifications have been based on predominant drug actions. These classifications have clinical and some experimental utility but fail to consider the complicated effects that pathophysiologic influences and pharmacologic actions may have on active and passive cellular properties. Cluster analysis may allow the development of new classifications of arrhythmogenesis and antiarrhythmic drugs. The matrical concept has important clinical implications and suggest strategies for treating patients with cardiac rhythm disturbances.

[1]  E. V. Vaughan Williams.  A classification of antiarrhythmic actions reassessed after a decade of new drugs. , 1984, Journal of clinical pharmacology.

[2]  M. Arnsdorf,et al.  A Metrical Approach to the Basic and Clinical Pharmacology of Antiarrhythmic Drugs , 1987, Reviews in clinical & basic pharmacology.

[3]  S. Nattel,et al.  Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity. , 1987, Circulation.

[4]  G. Sawicki,et al.  The Effects of Lysophosphatidylcholine, a Toxic Metabolite of Ischemia, on the Components of Cardiac Excitability in Sheep , 1981, Circulation research.

[5]  B. Katzung,et al.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. , 1977, Biochimica et biophysica acta.

[6]  M. Arnsdorf.  A Matrical Perspective of Cardiac Excitability, Cable Properties, and Impulse Propagation , 1989 .

[7]  H. Fozzard,et al.  Adrenergic Modulation of the Transient Outward Current in Isolated Canine Purkinje Cells , 1988, Circulation research.

[8]  J. Mason,et al.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. , 1984, Circulation research.

[9]  C F Starmer,et al.  Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics. , 1984, Biophysical journal.

[10]  E. Carmeliet.  Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  M. Arnsdorf.  The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers. , 1977, The Journal of pharmacology and experimental therapeutics.

[12]  M. Arnsdorf.  Basic understanding of the electrophysiologic actions of antiarrhythmic drugs. Sources, sinks, and matrices of information. , 1984, The Medical clinics of North America.

[13]  P. Corr,et al.  Amphipathic metabolites and membrane dysfunction in ischemic myocardium. , 1984, Circulation research.

[14]  U. Borchard,et al.  Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects. , 1988, Arzneimittel-Forschung.

[15]  B. Hille,et al.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reaction , 1977, The Journal of general physiology.

[16]  M. Rosen,et al.  Mechanisms of Action of Antiarrhythmic Drugs , 1973, Circulation research.

[17]  G. Sawicki,et al.  Effects of quinidine sulfate on the balance among active and passive cellular properties that comprise the electrophysiologic matrix and determine excitability in sheep Purkinje fibers. , 1987, Circulation research.

[18]  M. Arnsdorf,et al.  Membrane factors in arrhythmogenesis: concepts and definitions. , 1977, Progress in cardiovascular diseases.

[19]  M. Arnsdorf,et al.  Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction. , 1978, The Journal of pharmacology and experimental therapeutics.